1.
J Pediatric Infect Dis Soc
; 13(5): 285-287, 2024 May 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38591356
RESUMO
Nineteen youth living with HIV (YLWH) opted for injectable cabotegravir and rilpivirine without oral lead in and without achieving an undetectable HIV viral load (VL) for the 3 months prior to initiation. All achieved undetectable status within 3 months (3 injections) and maintained an undetectable status through 6-12 months of therapy.